Pharma IQ Members

Rainer
Beck

Rainer Beck
"I think when we are going back five years ago, and I am talking now of Novartis, we have had the classical approach, which can be called Demand Focused. The main target of this business model was to secure the supply and the key decision driver was pricing. This was five years ago. In the meantime, we have had another phase we called...Full Article »